CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues:
Total revenues	$ 10,054	$ 9,179	$ 18,672	$ 17,328
Operating expenses:
Cost of sales	2,811	3,011	5,555	5,979
Research and development	1,868	1,744	3,587	3,230
Selling, general and administrative	1,745	1,691	3,347	3,378
Other	116	77	3	907
Total operating expenses	6,540	6,523	12,492	13,494
Operating income	3,514	2,656	6,180	3,834
Other income (expense):
Interest expense, net	(673)	(694)	(1,330)	(1,417)
Other (expense) income, net	(73)	(394)	2	1,124
Income before income taxes	2,768	1,568	4,852	3,541
Provision for income taxes	393	136	658	379
Net income	$ 2,375	$ 1,432	$ 4,194	$ 3,162
Earnings per share:
Basic (in usd per share)	$ 4.40	$ 2.66	$ 7.77	$ 5.88
Diluted (in usd per share)	$ 4.37	$ 2.65	$ 7.71	$ 5.84
Weighted-average shares used in calculation of earnings per share:
Basic (in shares)	540	538	540	538
Diluted (in shares)	544	541	544	541
Product sales
Revenues:
Total revenues	$ 9,537	$ 8,771	$ 17,755	$ 16,644
Other revenues
Revenues:
Total revenues	$ 517	$ 408	$ 917	$ 684

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income	$ 4,194	$ 3,162
Noncash adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	2,228	2,728
Impairment of intangible assets	0	800
Stock-based compensation expense	240	242
Deferred income taxes	(467)	(672)
Loss (gain) on equity securities	301	(741)
Other items, net	8	(73)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables, net	(680)	(1,823)
Inventories	(13)	527
Other assets	(322)	(407)
Accounts payable	501	1,086
Accrued income taxes, net	(60)	(2,313)
Long-term tax liabilities	148	162
Accrued liabilities	(58)	(50)
Accrued sales incentives and allowance	278	1,113
Other liabilities	(107)	(70)
Net cash provided by operating activities	6,191	3,671
Cash flows from investing activities:
Purchases of property, plant and equipment	(1,225)	(780)
Other	(60)	(56)
Net cash used in investing activities	(1,285)	(836)
Cash flows from financing activities:
Net proceeds from issuance of debt	3,964	0
Extinguishment of debt	(233)	(602)
Repayment of debt	(833)	(3,500)
Dividends paid	(2,720)	(2,559)
Other	(224)	(119)
Net cash used in financing activities	(46)	(6,780)
Increase (decrease) in cash and cash equivalents	4,860	(3,945)
Cash and cash equivalents at beginning of period	9,129	11,973
Cash and cash equivalents at end of period	$ 13,989	$ 8,028

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 13,989	$ 9,129
Trade receivables, net	10,227	9,570
Inventories	6,220	6,225
Other current assets	4,525	4,133
Total current assets	34,961	29,057
Property, plant and equipment, net	8,547	7,913
Intangible assets, net	20,487	22,276
Goodwill	18,668	18,680
Other noncurrent assets	12,976	12,660
Total assets	95,639	90,586
Current liabilities:
Accounts payable	2,865	2,367
Accrued liabilities	17,192	18,523
Current portion of long-term debt	5,445	4,599
Total current liabilities	25,502	25,489
Long-term debt	51,859	50,005
Long-term deferred tax liabilities	1,301	1,366
Long-term tax liabilities	2,844	2,690
Other noncurrent liabilities	2,445	2,378
Contingencies and commitments (see Note 13)
Stockholders’ equity:
Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding—540.6 shares in 2026 and 538.8 shares in 2025	34,082	34,023
Accumulated deficit	(22,275)	(25,107)
Accumulated other comprehensive loss	(119)	(258)
Total stockholders’ equity	11,688	8,658
Total liabilities and stockholders’ equity	$ 95,639	$ 90,586